High-Quality Products in Gastroenterology

SOLVAY PHARMACEUTICALS PROVIDES ITS CUSTOMERS WITH HIGH-QUALITY, SAFE AND WELL TOLERATED PRODUCTS IN IMPORTANT GASTRO-INTESTINAL INDICATIONS. THEY PLAY A MAJOR ROLE IN THE TREATMENT OF PANCREATIC EXOCRINE INSUFFICIENCY, IRRITABLE BOWEL SYNDROME, INFLAMMATORY BOWEL DISEASE AND CONSTIPATION. creon^®, duphalac^®, duspatalin^® / Colofac^®, and dicetel^® ARE HOUSEHOLD NAMES IN GASTROENTEROLOGY AND GENERAL PRACTICE. CONTINUED RESEARCH EFFORTS IN THESE AREAS LEAD TO INNOVATIVE NEW PRODUCTS AND INCREASED UNDERSTANDING OF THE UNDERLYING PATHOLOGIES.

Solvay Pharmaceuticals is a market leader, and the largest manufacturer, of pancreatic enzymes, with 90 years of experience in research and development in this field. The creon^® product line is indicated for the treatment of pancreatic exocrine insufficiency, caused by cystic fibrosis, chronic pancreatitis or pancreatic surgery. Solvay Pharmaceuticals advanced production technology has resulted in optimizing the size of the microspheres which make up each creon^® capsule. Consequently creon^® combines the features of fast, homogeneous distribution in the stomach with complete protection against inactivation by gastric juices. Innovative research and development continues.
With duspatalin^® / Colofac^® and dicetel^® Solvay Pharmaceuticals is a world leader in the treatment of irritable bowel syndrome. IBS is also one of Solvay Pharmaceuticals main GI research areas. Solvay invests more in this field in order to bring entirely new treatment approaches to IBS.

duphalac^®, the effective and well-tolerated laxative with positive long-term benefits, is the world's market leading lactulose. Continued clinical research indicates that duphalac^® may have several other beneficial effects, such as prevention of urinary tract infections. Solvay Pharmaceuticals houses the world's largest production center for lactulose liquid.

creon^® provides cystic fibrosis patients with the necessary enzyme supplements. Better absorption of food normalizes growth and results in better quality of life for the patient. Additional to a continued strive for progress in cystic fibrosis treatment, Solvay Pharmaceuticals is committed to educating and supporting patients in dealing with their disease.